MOESM7 of Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition

Additional file 7: Figure S6. BET Bromodomain Inhibition Downregulates PD-L1 and HLA-ABC in DU145 and PC3 xenograft tumors. C. Summary of flow cytometry data for PD-L1 staining in ex-vivo DU145 and PC3 tumors, gated on Live CD45− cells. N = 6 mice / iteration, repeated × 2. D. Summary of flow cytome...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Mao, Wendy, Ghasemzadeh, Ali, Freeman, Zachary T., Obradovic, Aleksandar, Chaimowitz, Matthew G., Nirschl, Thomas R., McKiernan, Emily, Srinivasan Yegnasubramanian, Drake, Charles G.
Format:	Video
Sprache:	eng
Schlagworte:	Cancer Chemical Sciences not elsewhere classified Computational Biology FOS: Chemical sciences FOS: Clinical medicine FOS: Computer and information sciences Immunology Information Systems not elsewhere classified Medicine Molecular Biology
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Additional file 7: Figure S6. BET Bromodomain Inhibition Downregulates PD-L1 and HLA-ABC in DU145 and PC3 xenograft tumors. C. Summary of flow cytometry data for PD-L1 staining in ex-vivo DU145 and PC3 tumors, gated on Live CD45− cells. N = 6 mice / iteration, repeated × 2. D. Summary of flow cytometry data for HLA-ABC staining in ex-vivo MC38OVA tumors gated on Live CD45− cells. N = 6 mice / iteration, repeated × 2.
DOI:	10.6084/m9.figshare.10052942